TFS
SAGE icon

TrustCore Financial Services’s Sage Therapeutics SAGE Stock Holding History

TrustCore Financial Services’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-8
Closed -$1K – 952
2018
Q2 		$1K Buy
+8
New +$1.26K ﹤0.01% 917

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
OppenheimerFunds
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BB Biotech
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

TrustCore Financial Services's SAGE Position: Q3 2018 in Review

TrustCore Financial Services sold out of Sage Therapeutics (SAGE) in Q3 2018, closing a stake of 8 shares — an estimated $1K sold.

TrustCore Financial Services first reported a position in SAGE in Q2 2018 and held it in 1 quarter. The position peaked at $1K in Q2 2018. 275 funds tracked by Wall St. Rank hold SAGE as of Q3 2018.

  • TrustCore Financial Services reported no remaining Sage Therapeutics position as of Q3 2018 after selling out during the quarter.
  • TrustCore Financial Services sold 8 Sage Therapeutics shares in Q3 2018, an estimated $1K.
  • TrustCore Financial Services first reported a position in Sage Therapeutics in Q2 2018 and held it in 1 quarter.
  • TrustCore Financial Services's Sage Therapeutics position peaked at $1K in Q2 2018.
  • 275 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2018.

Based on TrustCore Financial Services's 13F filing for Q3 2018, filed 9 Nov 2018.